• Browse Industries
• Health Care

• AdvaMed SmartBrief
• News
• Press Releases
• SmartBlogs
• Topics
• Bioethics
• Cancer
• Cardiac devices
• Diagnostics
• Electronic medical records
• Genetic Research
• Imaging
• Nanotechnology
• Orthopedics
• Scientific Discoveries
• Jobs
• View Job Listings
• Post a Job
• Job Listings FAQ's
• Most Clicked Stories
• ADVAMED News
• ADVAMED Reader Polls
• Archive
• RSS

• Find/Post Jobs

• Partner With Us

• Advertise

• About SmartBrief

• Reader Polls

Stryker Biotech faces charges alleging off-label marketing of devices

Federal prosecutors in Boston filed an indictment against Stryker Biotech and some of its current and former employees on charges that it allegedly marketed devices for uses not approved by the FDA. Stryker Corp., the unit's parent company, said it "is disappointed with this action and still hopes to be able to reach a fair and just resolution to the matter."

Boston Herald | 10/28

This story published in AdvaMed SmartBrief on 10/29/2009

Get stories like these delivered daily for FREE:

AdvaMed SmartBrief Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more